Blood Res  
Molecular screening for an underlying myeloproliferative neoplasm in patients with stroke: who and how?
Stephen E. Langabeer
Cancer Molecular Diagnostics, St. James’s Hospital, Dublin, Ireland
Correspondence to: Stephen E. Langabeer, Ph.D.
Cancer Molecular Diagnostics, Trinity Translational Medicine Institute, St. James’s Hospital, Dublin, D08 W9RT, Ireland
E-mail: slangabeer@stjames.ie
Published online: March 13, 2020.
© The Korean Journal of Hematology. All rights reserved.



e-submission

This Article

Current Issue

ba_link01

Indexed/Covered by

Today : 38  /
Total : 190,574